Turkish Acquired Haemophilia Registry

Observational Acquired Haemophilia Registry

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01403740

Acronym

EHEM

Enrollment

250

Registered

2011-07-27

Start date

2011-09-30

Completion date

2013-08-31

Last updated

2011-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Haemophilia

Keywords

acquired haemophilia, factor VIII

Brief summary

Turkish Acquired Haemophilia Registry is a database in which information about clinical features and therapeutic management of acquired haemophilia is collected in Turkey.This is a multicentre, retrospective and prospective registry of subjects diagnosed and/or treated for acquired haemophilia. Patients will be registered and the response to different therapies, details of each bleeding episode and the outcome of haemostatic and immunosuppressive therapy (IST) will be recorded. Any male or female subject diagnosed with inhibitors to FVIII or other factors and treated for acquired haemophilia can be entered on the registry. Patients will be treated according to local practice. No additional tests or procedures are required by the registry. The retrospective period will not be time-limited and data will be collected from those recorded in the hospital notes. The prospective period will begin in September 1.2011, and will last for two years.

Interventions

DRUGrFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin

According to local clinical standards

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Acquired haemophilia diagnosis, written consent

Exclusion criteria

* Being unable to give written consent

Countries

Turkey (Türkiye)

Contacts

Primary ContactDilek Solakoglu, MD

dileksolakoglu@cortexiletisim.com902123253232

Backup ContactVolkan Aydin, MD

volkanaydin@cortexiletisim.com902123253232

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026